Clinical Trial Update: Clinical Trial of Oral Ciprofloxacin and Etoposide in Subjects With Resistant Acute Myeloid Leukemia (AML)(UF-AML-CE-101) [Phase 1, Phase 2]

View source ↗

Summary

An early-phase clinical trial investigating oral ciprofloxacin and etoposide in resistant acute myeloid leukemia was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Leukemia

Drugs mentioned

• Ciprofloxacin (Ciprofloxacin hydrochloride)
• Etoposide (Etoposide)

Snippet

Sponsor: University of Florida | Conditions: Leukemia, Acute Myelogenous Leukemia | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2022-08-05